Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Smoking and Graves' disease.

Literature DB >> 12035933

Smoking and Graves' disease.

Luigi Bartalena.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 12035933 DOI： 10.1007/BF03344027

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

× No keyword cloud information.

7 in total

1. More on smoking habits and Graves' ophthalmopathy.

Authors: L Bartalena; E Martino; C Marcocci; F Bogazzi; M Panicucci; F Velluzzi; A Loviselli; A Pinchera
Journal: J Endocrinol Invest Date: 1989-11 Impact factor: 4.256

Review 2. Cigarette smoking and the thyroid.

Authors: L Bartalena; F Bogazzi; M L Tanda; L Manetti; E Dell'Unto; E Martino
Journal: Eur J Endocrinol Date: 1995-11 Impact factor: 6.664

Review 3. Management of Graves' ophthalmopathy: reality and perspectives.

Authors: L Bartalena; A Pinchera; C Marcocci
Journal: Endocr Rev Date: 2000-04 Impact factor: 19.871

4. Does smoking increase relapse rates in Graves' disease?

Authors: L E Kimball; E Kulinskaya; B Brown; C Johnston; N R Farid
Journal: J Endocrinol Invest Date: 2002-02 Impact factor: 4.256

5. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.

Authors: D Glinoer; P de Nayer; M Bex
Journal: Eur J Endocrinol Date: 2001-05 Impact factor: 6.664

6. Clinical, biochemical and immunological characteristics of relapsers and non-relapsers of thyrotoxicosis treated with anti-thyroid drugs.

Authors: T A Chowdhury; P H Dyer
Journal: J Intern Med Date: 1998-10 Impact factor: 8.989

7. Smoking and risk of Graves' disease.

Authors: M F Prummel; W M Wiersinga
Journal: JAMA Date: 1993-01-27 Impact factor: 56.272

7 in total

1. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.

Authors: G Mastorakos; A G Doufas; E Mantzos; J Mantzos; D A Koutras
Journal: J Endocrinol Invest Date: 2003-10 Impact factor: 4.256

Smoking and Graves' disease.

1. More on smoking habits and Graves' ophthalmopathy.

Review 2. Cigarette smoking and the thyroid.

Review 3. Management of Graves' ophthalmopathy: reality and perspectives.

4. Does smoking increase relapse rates in Graves' disease?

5. Effects of l-thyroxine administration, TSH-receptor antibodies and smoking on the risk of recurrence in Graves' hyperthyroidism treated with antithyroid drugs: a double-blind prospective randomized study.

6. Clinical, biochemical and immunological characteristics of relapsers and non-relapsers of thyrotoxicosis treated with anti-thyroid drugs.

7. Smoking and risk of Graves' disease.

1. T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.

Review 2. Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.

3. Graves' ophthalmopathy: search for shared autoantigen(s) continues.

Review 4. Advances in the management of thyroid eye diseases: An overview.

5. Orbital radiotherapy for Graves' ophthalmopathy: useful or useless? Safe or dangerous?

Review 6. Relationship between management of hyperthyroidism and course of the ophthalmopathy.

Review 7. Graves' ophthalmopathy: state of the art and perspectives.